Bangladesh measles death toll passes 1,000 as vaccination gaps persist

A preventable outbreak reaches a grim threshold

Bangladesh’s measles outbreak has killed at least 1,002 children since it began in March, according to health-service figures reported on September 9. Officials also recorded 187,484 infections, making the epidemic one of the gravest current tests of the country’s public-health system. The threshold is especially consequential because measles is preventable with a two-dose vaccine, yet the virus can spread rapidly where routine coverage has weakened. Hospitals are treating the outbreak while also confronting a rise in dengue admissions.

The reported toll is far higher than the figures available in late June. A United Nations situation report covering June 25 listed more than 95,760 suspected cases, 11,390 confirmed cases and separate suspected and confirmed death counts. It also found that children younger than five represented 81 percent of reported cases. The difference between confirmed and suspected classifications remains important, but both the UN data and the latest national figures establish sustained, nationwide transmission and severe pressure on young children.

A large campaign still left critical gaps

Bangladesh launched emergency measles-rubella vaccination in April with support from UNICEF, the World Health Organization and Gavi. The initial operation targeted more than 1.2 million children between six months and five years old in 30 high-risk subdistricts before expanding nationally. By late June, the UN reported that more than 18.4 million children had been vaccinated. That scale demonstrates a major mobilisation, but national officials told Al Jazeera that roughly four million children were still not reached.

The remaining gap helps explain why transmission has continued despite the campaign’s headline coverage. Missed children are not necessarily distributed evenly: densely populated neighbourhoods, mobile families, disrupted routine services and communities with limited access can sustain local chains of infection. Political turmoil in 2024 and 2025 also disrupted procurement and immunisation schedules, according to health officials and international agencies. Restoring routine vaccination will therefore matter alongside emergency doses, surveillance, hospital capacity and outreach to families missed during the first campaign.

The next indicators are whether weekly case numbers decline consistently, whether teams locate the remaining unvaccinated children and whether hospitals can manage severe complications without displacing other essential care. Authorities will also need to publish comparable suspected and laboratory-confirmed totals so the trajectory can be assessed accurately. The latest death toll is supported by Bangladesh health officials as reported by Al Jazeera; the UN’s earlier figures independently verify the scale, geographic spread and vaccination response rather than the new September total.